PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550646
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550646
Global coronary artery bypass grafting market is estimated to be valued at USD 14.02 Bn in 2024 and is expected to reach USD 26.15 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 14.02 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 9.30% | 2031 Value Projection: | US$ 26.15 Bn |
Coronary artery bypass grafting (CABG) is a type of surgery that improves blood flow to the heart. It is used to treat people with severe coronary artery disease that has not responded well to other treatments. The main purpose of the surgery is to bypass narrow or blocked sections of the coronary arteries with healthy blood vessels, usually taken from the chest, arm, or leg of the patient. This improves blood flow and oxygen delivery to the heart muscle, thus, relieving symptoms of chest pain or pressure (angina) and reducing the risk of heart attack. Coronary artery bypass grafting is one of the most commonly performed cardiac surgeries worldwide.
Market Dynamics:
Global coronary artery bypass grafting market growth is driven by increasing prevalence of heart disease across both developing and developed nations. High blood pressure, diabetes, obesity and lack of physical activity has increased cardiovascular cases, thus, boosting demand for CABG procedures. Favorable reimbursement policies for cardiac treatments in developed countries and growing medical tourism in emerging economies can offer opportunities for market growth. However, development of innovative minimally invasive endovascular techniques for coronary revascularization can hamper the market growth as these result in less complications and faster recovery times as compared to open-chest CABG surgery. The market players could overcome this restraint by integrating robotic and navigation technologies to make CABG safer and less complex.
This report provides in-depth analysis of the global coronary artery bypass grafting market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global coronary artery bypass grafting market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Terumo, MAQUET, Boston Scientific, C. R. Bard and Edwards Lifesciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global coronary artery bypass grafting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary artery bypass grafting market
Detailed Segmentation-